Striatech Backs ARVO’s Rising Vision Scientist
At Striatech, advancing the future of ophthalmic research is a central commitment. In partnership with the ARVO Foundation for Eye
Read moreAt Striatech, advancing the future of ophthalmic research is a central commitment. In partnership with the ARVO Foundation for Eye
Read moreA groundbreaking study by Groh et al., recently featured in Nature Communications, delves into the interplay between adaptive immunity and
Read moreDarkAdapt, an advanced extension of the OptoDrum system, enables precise and reproducible studies with dark-adapted rodents. This innovative instrument provides
Read moreGroundbreaking research from Harvard Medical School indicates that vision loss caused by optic nerve damage, glaucoma, and aging may not
Read moreThe Ksander Lab at Boston’s Schepens Eye Research Institute has unveiled valuable insights into the role of subretinal microglia in
Read moreMillions of individuals worldwide are affected by vision loss caused by retinal degenerative diseases, such as retinitis pigmentosa (RP) and
Read moreSeNostic is Revolutionising Neurodegenerative Disease Detection and Drug Discovery with Cutting-Edge Technology A SeNostic Company Presentation SeNostic aims to enhance
Read moreAbbVie has reported positive topline results from its pivotal Phase 3 TEMPO-1 trial evaluating tavapadon as a monotherapy for early-stage
Read moreIn a groundbreaking leap, researchers have engineered microscopic magnetic robots that could transform the treatment of deadly brain bleeds caused
Read moreGroundbreaking Research Highlights ipRGCs as Promising Biomarkers for Neurodegenerative Diseases A Striatech .pdf Case Study OptoDrum plays a key role
Read more